Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07648953

Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

This exploratory mixed-methods study aims to examine receipt of treatment and decision-making among rural cancer patients in Utah. Guided by Conceptual Model of Healthcare Access, the study will integrate, survey and cancer registry data with patient interviews to better understand how travel burden, socioeconomic conditions, health literacy, and other contextual factors shape treatment location and access to care . While the setting of this research is specific to Utah, a state with vast rural regions and only one National Cancer Institute (NCI)-designated cancer center, the findings may inform policy and practice improvements in other states with similar geographic and healthcare infrastructure. Thus, the study has potential relevance for advancing rural cancer equity nationwide.

Understanding how rural cancer patients make treatment decisions is essential to addressing persistent disparities in cancer care access and outcomes. While geographic barriers and structural inequities are well-documented, less is known about the individual and contextual factors that shape patients' choices about where and how to receive treatment. This mixed-methods study will examine receipt of treatment, decision-making, and patient experience among rural cancer patients in Utah, with attention to travel burden, referral pathways, health literacy, and perceived barriers to care.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

HPV VACCINATION

Age range

18 year–26 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Utah

Salt Lake City, Utah, 84112, United States

Location status: Recruiting

Location contact

Echo Warner, MPH, PhD, SB

CONTACT

[email protected]

801-244-7040

Echo Warner, MPH, PhD, SB

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.
  • Currently use Facebook or willing to create a Facebook account to use for the duration of the study.
  • At the time of enrollment, have not completed all recommended doses of the HPV vaccine.

Exclusion criteria

  • Unable to speak and understand English.
  • Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.
  • Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.

Treatment and study plan

Microvideos: HPV Vaccination Education

Behavioral

To educate survivors of childhood cancers about a key cancer prevention strategy, HPV vaccination. The core microvideos will focus on the 5 Ws of HPV vaccination: Who should get vaccinated, What HPV vaccination protects against, When to get vaccinated, Where to access the vaccine, Why it matters-designed particularly for cancer survivors.

Primary outcomes

  1. Feasibility of Microvideo education

    Time frame: up to 4 weeks

    Feasibility will be defined as ≥80% of participants completing the intervention and study surveys.

Secondary outcomes

  1. Acceptability of Microvideo Education

    Time frame: up to 4 weeks

    Acceptability will be summarized using means, standard deviations, and proportions of participants indicating strong agreement (scores ≥4 out of 5) with positive statements about the microvideos and platform.

    Scores range from 0-5, with higher scores indicating more positivity about the microvideos and platform, and lower scores indicating less positivity about the microvideos and platform.

  2. Satisfaction Acceptability of Microvideo Education

    Time frame: up to 4 weeks

    Satisfaction will be summarized using means, standard deviations, and proportions of participants indicating strong agreement (scores ≥4 out of 5) with positive statements about the microvideos and platform.

    Scores range from 0-5, with higher scores indicating more positivity about the microvideos and platform, and lower scores indicating less positivity about the microvideos and platform.

  3. HPV Vaccine Intention

    Time frame: up to 4 weeks

    To assess HPV vaccine intention among unvaccinated emerging adult survivors of childhood cancer through a pilot quasi-experimental social media intervention.

    This outcome measure will report the count of participants who intended to receive the HPV Vaccine after the microvideo education.

Study contacts

Contact information is provided by the study sponsor or research team.

Echo Warner, MPH, PhD, SB

CONTACT

[email protected]

801-244-7040

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Collaborators

  • Huntsman Cancer Institute
  • Prevent Cancer Foundation

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 15, 2026
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.